Results 21 to 30 of about 17,208,238 (361)

Drug Design—Past, Present, Future

open access: yesMolecules, 2022
Drug design is a complex pharmaceutical science with a long history. Many achievements have been made in the field of drug design since the end of 19th century, when Emil Fisher suggested that the drug–receptor interaction resembles the key and lock ...
I. Doytchinova
semanticscholar   +1 more source

Dipeptide of ψ-GSH Inhibits Oxidative Stress and Neuroinflammation in an Alzheimer’s Disease Mouse Model

open access: yesAntioxidants, 2022
Supplementation of glutathione (GSH) levels through varying formulations or precursors has thus far appeared to be a tenable strategy to ameliorate disease-associated oxidative stress.
Abbas Raza   +6 more
doaj   +1 more source

The Expanding Role of Pyridine and Dihydropyridine Scaffolds in Drug Design

open access: yesDrug Design, Development and Therapy, 2021
Pyridine-based ring systems are one of the most extensively used heterocycles in the field of drug design, primarily due to their profound effect on pharmacological activity, which has led to the discovery of numerous broad-spectrum therapeutic agents ...
Yong Ling   +5 more
semanticscholar   +1 more source

Blood–brain barrier penetration prediction enhanced by uncertainty estimation

open access: yesJournal of Cheminformatics, 2022
Blood–brain barrier is a pivotal factor to be considered in the process of central nervous system (CNS) drug development, and it is of great significance to rapidly explore the blood–brain barrier permeability (BBBp) of compounds in silico in early drug ...
Xiaochu Tong   +11 more
doaj   +1 more source

DKK1 inhibits breast cancer cell migration and invasion through suppression of β-catenin/MMP7 signaling pathway

open access: yesCancer Cell International, 2019
Background DKK1 has been reported to act as a tumor suppressor in breast cancer. However, the mechanism of DKK1 inhibits breast cancer migration and invasion was still unclear.
Jie Niu   +9 more
doaj   +1 more source

Targeting isoaspartate-modified Aβ rescues behavioral deficits in transgenic mice with Alzheimer’s disease-like pathology

open access: yesAlzheimer’s Research & Therapy, 2020
Background Amyloid β (Aβ)-directed immunotherapy has shown promising results in preclinical and early clinical Alzheimer’s disease (AD) trials, but successful translation to late clinics has failed so far.
Kathrin Gnoth   +16 more
doaj   +1 more source

4,7-Disubstituted 7H-Pyrrolo[2,3-d]pyrimidines and Their Analogs as Antiviral Agents against Zika Virus

open access: yesMolecules, 2021
Discovery of compound 1 as a Zika virus (ZIKV) inhibitor has prompted us to investigate its 7H-pyrrolo[2,3-d]pyrimidine scaffold, revealing structural features that elicit antiviral activity.
Ruben Soto-Acosta   +5 more
doaj   +1 more source

Artificial intelligence and machine learning approaches for drug design: challenges and opportunities for the pharmaceutical industries

open access: yesMolecular diversity, 2021
The global spread of COVID-19 has raised the importance of pharmaceutical drug development as intractable and hot research. Developing new drug molecules to overcome any disease is a costly and lengthy process, but the process continues uninterrupted ...
C. Selvaraj, I. Chandra, S. Singh
semanticscholar   +1 more source

LogD7.4 prediction enhanced by transferring knowledge from chromatographic retention time, microscopic pKa and logP

open access: yesJournal of Cheminformatics, 2023
Lipophilicity is a fundamental physical property that significantly affects various aspects of drug behavior, including solubility, permeability, metabolism, distribution, protein binding, and toxicity.
Yitian Wang   +13 more
doaj   +1 more source

Enhanced Remdesivir Analogues to Target SARS-CoV-2

open access: yesMolecules, 2023
We report the short synthesis of novel C-nucleoside Remdesivir analogues, their cytotoxicity and an in vitro evaluation against SARS-CoV-2 (CoV2). The described compounds are nucleoside analogues bearing a nitrogen heterocycle as purine analogues.
Ryuichi Majima   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy